NCT06670092

Brief Summary

ADHD is generally associated with significant comorbidities including motor disorders in up to 96% of cases. Within these, disturbances of balance and motor coordination that interfere with school learning and daily activities are present in 47% of school children with ADHD. Therefore, the aim of this research is to determine whether Vojta therapy is beneficial for the improvement of balance, postural control, hand-eye coordination and manipulative motor skills in children with ADHD, hyperactive and/or combined, aged 6-12 years.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Nov 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 31, 2024

Completed
1 day until next milestone

First Posted

Study publicly available on registry

November 1, 2024

Completed
29 days until next milestone

Study Start

First participant enrolled

November 30, 2024

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 20, 2025

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

March 3, 2025

Completed
Last Updated

March 7, 2025

Status Verified

March 1, 2025

Enrollment Period

2 months

First QC Date

October 31, 2024

Last Update Submit

March 4, 2025

Conditions

Keywords

Attention-Deficit/Hyperactivity DisorderVojta Therapybalancepostural controlvisual motor coordinationmanipulative skills

Outcome Measures

Primary Outcomes (1)

  • Sensory organisation test (NEUROCOM dynamic posturology)

    This test is a commonly used research tool in the assessment of the sensory organisation of postural control and has previously been used in children. The system's force platform provides data on the movement of the centre of gravity. Both the platform and the environment can move in response to the anteroposterior displacement of the child's body under certain conditions of sensory override or conflict. The child is asked to stand upright, barefoot, with arms alongside the body, feet placed in a certain position on the platform, for 20sec, trying to remain as stable as possible during the 3 trials of each of the 6 conditions of the SOT. For their safety, the child shall be restrained by a harness. In each test, the system compares the child's displacement with its theoretical limits of stability, generating a score. The higher the value, the better the stability. The software also calculates an overall score from the scores obtained in each of the 6 conditions

    15 minutes

Secondary Outcomes (3)

  • Paediatric Balance Scale

    15 minutes

  • Bruininks-Oseretsky Test (abbreviated version)

    10 minutes

  • Paediatric Quality of Life Questionnaire

    10 minutes

Study Arms (2)

Experimental group

EXPERIMENTAL

This group is treated according to Vojta therapy

Other: Vojta Therapy

Control group

OTHER

This group does not receive treatment

Other: No intervetion

Interventions

The intervention is carried out using Vojta therapy for one month, with one session per day, 5 days a week. This therapy is carried out by an expert physiotherapist. Vojta therapy is a non-experimental, painless, non-invasive therapy with no adverse effects, which is based on triggering repeated motor reactions or innate movement patterns (reflex locomotion patterns) in the trunk and limbs based on defined stimuli and starting from specific postures. Both groups will undertake a pre-treatment assessment, a post-treatment assessment at the end of the one-month intervention period, and a final follow-up assessment one month after the end of the intervention.

Experimental group

No intervetion group

Also known as: No intervention group
Control group

Eligibility Criteria

Age6 Years - 12 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Have a diagnosis of Attention Deficit Hyperactivity Disorder (ADHD) of the combined or hyperkinetic type.
  • Be between 6 and 12 years of age.
  • Be under treatment with methylphenidate.
  • IQ of 100 or higher.
  • Have a normal neurological examination.
  • Not dysmorphic.

You may not qualify if:

  • Present a diagnosis of ADHD comorbid with other neuropsychiatric pathologies.
  • Have a history of neurological or musculoskeletal disorders that are linked to a deficit in balance and/or postural control.
  • Be under treatment with atomoxetine.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Universidad Rey Juan Carlos

Alcorcón, Madrid, 28922, Spain

Location

MeSH Terms

Conditions

Attention Deficit Disorder with Hyperactivity

Condition Hierarchy (Ancestors)

Attention Deficit and Disruptive Behavior DisordersNeurodevelopmental DisordersMental Disorders

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal investigator

Study Record Dates

First Submitted

October 31, 2024

First Posted

November 1, 2024

Study Start

November 30, 2024

Primary Completion

January 20, 2025

Study Completion

March 3, 2025

Last Updated

March 7, 2025

Record last verified: 2025-03

Data Sharing

IPD Sharing
Will share

Locations